Potential roles of vessel wall heparan sulfate proteoglycans in atherosclerosis

Rosalinda Madonna1, Raffaele De Caterina2

  • 1"G. d'Annunzio" University-Chieti, Italy.

Vascular Pharmacology
|December 17, 2013
PubMed

Insights

Heparan sulfate proteoglycans (HSPGs) in blood vessels are regulated by stress and influence atherosclerosis. Their interactions with cells are key to disease progression.

Area of Science:

  • Vascular Biology
  • Proteoglycan Research
  • Atherosclerosis Studies

Background:

  • Heparan sulfate proteoglycans (HSPGs) are crucial components in various blood vessel compartments and cell types.
  • HSPG expression and heparanase activity are tightly regulated, responding to metabolic and environmental stresses like diabetes.
  • Dysregulation of HSPGs is implicated in the pathogenesis of atherosclerotic vascular disease.

Purpose of the Study:

  • To review the multifaceted roles of vascular wall-expressed HSPGs in the context of atherosclerotic vascular disease.
  • To highlight how HSPG functions, including monocyte adhesion and LDL binding, contribute to atherosclerosis development.

Main Methods:

  • Literature review focusing on the expression and function of HSPGs in the vascular wall.
  • Analysis of studies investigating the impact of HSPGs on cellular interactions relevant to atherosclerosis.
  • Examination of the regulation of HSPGs and heparanase in response to disease-related stresses.

Main Results:

  • HSPGs mediate critical cellular interactions, such as monocyte adhesion and smooth muscle cell proliferation, that drive atherosclerosis.
  • Binding of low-density lipoproteins (LDL) to HSPGs is a significant factor in atherosclerotic lesion formation.
  • Changes in HSPG expression and heparanase activity under stress conditions, including diabetes, correlate with disease progression.

Conclusions:

  • Vascular HSPGs play a pivotal role in the development and progression of atherosclerotic vascular disease.
  • Understanding HSPG-cell interactions and their regulation is essential for developing therapeutic strategies against atherosclerosis.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
6.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K